Eléments de l'association

	Lawrence Cher	1
	Antineoplastic Combined Chemotherapy Protocols (therapeutic use)	22
	Lawrence Cher *Sauf* Antineoplastic Combined Chemotherapy Protocols (therapeutic use)"	0
	Antineoplastic Combined Chemotherapy Protocols (therapeutic use) *Sauf* Lawrence Cher"	21
	Lawrence Cher Et Antineoplastic Combined Chemotherapy Protocols (therapeutic use)	1
	Lawrence Cher Ou Antineoplastic Combined Chemotherapy Protocols (therapeutic use)	22
	*Corpus*	3114

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000F10	Tracy T. Batchelor [États-Unis] ; Paul Mulholland [Royaume-Uni] ; Bart Neyns [Belgique] ; L. Burt Nabors [États-Unis] ; Mario Campone [France] ; Antje Wick [Allemagne] ; Warren Mason [Canada] ; Tom Mikkelsen [États-Unis] ; Surasak Phuphanich [États-Unis] ; Lynn S. Ashby [États-Unis] ; John Degroot [États-Unis] ; Rao Gattamaneni [Royaume-Uni] ; Lawrence Cher [États-Unis] ; Mark Rosenthal [Australie] ; Franz Payer [Autriche] ; Juliane M. Jürgensmeier [États-Unis] ; Rakesh K. Jain [États-Unis] ; A. Gregory Sorensen [États-Unis] ; John Xu [États-Unis] ; QI LIU [États-Unis] ; Martin Van Den Bent [Pays-Bas]	Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024